Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “BLADDER AND BOWEL DYSFUNCTION”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01135849
What this trial is testing

B-Receptor Signaling in Cardiomyopathy

Who this might be right for
CarcinomasAmyloidosisAnal Cancer+35 more
Daniel Bernstein 99
Testing effectiveness (Phase 2)Looking for participantsNCT05944237
What this trial is testing

HTL0039732 in Participants With Advanced Solid Tumours

Who this might be right for
NeoplasmsProstatic Neoplasms, Castration-ResistantStomach Neoplasms+11 more
Cancer Research UK 150
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Not applicableStudy completedNCT00737230
What this trial is testing

Care of Cancer Patients With Bowel Injury Caused by Radiation Therapy to the Pelvis

Who this might be right for
Cancer
Royal Marsden NHS Foundation Trust 250
Early research (Phase 1)Active Not RecruitingNCT06617169
What this trial is testing

Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors

Who this might be right for
Solid Tumor, AdultBladder CancerUrothelial Carcinoma+6 more
Monopar Therapeutics 12
Not applicableActive Not RecruitingNCT06333886
What this trial is testing

Use of Point-of-care Neuro-sacral Electrophysiology Following Spinal Cord Injury

Who this might be right for
Spinal Cord InjuriesNeurogenic BowelNeurogenic Bladder Dysfunction
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal 450
Not applicableUnknownNCT03668418
What this trial is testing

Xenotransplantation of Primary Cancer Samples in Zebrafish Embryos

Who this might be right for
Liver CancerPancreatic CancerGastric Cancer+4 more
University of Pisa 120
Early research (Phase 1)Study completedNCT00005858
What this trial is testing

LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+3 more
University of Maryland, Baltimore 25
Not applicableActive Not RecruitingNCT05179824
What this trial is testing

Tempus Priority Study: A Pan-tumor Observational Study

Who this might be right for
Breast CancerProstate CancerBladder Cancer+24 more
Tempus AI 1,000
Not applicableEnded earlyNCT05163262
What this trial is testing

Descriptive and Prospective Study of Sphincter Disorders in the Severe Traumatic Brain Injury Population

Who this might be right for
Traumatic Brain Injury
Assistance Publique - Hôpitaux de Paris 8
Not applicableNot Yet RecruitingNCT07732686
What this trial is testing

Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry

Who this might be right for
Pancreas CancerHepatocellular CarcinomaLung Cancer+6 more
University of Oklahoma 2,000
Not applicableStudy completedNCT04670445
What this trial is testing

Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer

Who this might be right for
Stage IV MelanomaAdvanced Lung CancerStage IV Non-Small Cell Lung Cancer+19 more
Massachusetts General Hospital 199
Testing effectiveness (Phase 2)Ended earlyNCT04066894
What this trial is testing

Sacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE Study

Who this might be right for
Low Anterior Resection SyndromeMalignant Anal NeoplasmMalignant Bladder Neoplasm+8 more
M.D. Anderson Cancer Center 3
Not applicableStudy completedNCT03742570
What this trial is testing

Turkish Version of Childhood Bladder and Bowel Dysfunction Questionnaire

Who this might be right for
Children
Okan University 85
Not applicableStudy completedNCT04566614
What this trial is testing

Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid Biopsies

Who this might be right for
Neoplasm, ColorectalNeoplasm of LungNeoplasm, Bladder+3 more
Royal Marsden NHS Foundation Trust 128
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Early research (Phase 1)Ended earlyNCT04234113
What this trial is testing

Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors

Who this might be right for
Thyroid CancerRenal Cell CarcinomaNon Small Cell Lung Cancer+16 more
SOTIO Biotech AG 115
Not applicableStudy completedNCT06928220
What this trial is testing

The Impact of Manual Versus Mechanical Intestinal Suturing on the Incidence of Postoperative Complications Following Cystectomy With Ileal Conduit

Who this might be right for
Bladder CancerAnastomosis; ComplicationsIleus Paralytic
Fundacio Puigvert 120
Testing effectiveness (Phase 2)Ended earlyNCT05563272
What this trial is testing

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

Who this might be right for
Cervical CancerColorectal CancerEsophageal Cancer+16 more
Telix Pharmaceuticals (Innovations) Pty Ltd 11
Not applicableStudy completedNCT04166240
What this trial is testing

Measuring and Improving the Safety of Test Result Follow-Up

Who this might be right for
Lung CancerBreast CancerColon Cancer+2 more
VA Office of Research and Development 46
Next Page